Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise
PR99735
LISBON, Portugal, March 8, 2023 /PRNewswire=KYODO JBN/--
Hovione, the leader in spray drying and particle engineering, won the 2023 CDMO
Leadership Award (https://www.cmoleadershipawards.com/) across all six
categories – capability, compatibility, expertise, quality, reliability and
service across all three groups of respondents (Big Pharma, Small Pharma, and
Overall (combined Big and Small Pharma)). Hovione was given additional
recognition as a CDMO Leadership Award Champion in the categories of
Compatibility and Expertise for scoring as a top performer in comparison to the
weighted average of other CDMOs included in the Industry Standard Research
(ISR)’s annual Contract Manufacturing Quality Benchmarking survey.
Established in 2011 by Outsourced Pharma and Life Science Leader, the CDMO
Leadership Awards spotlight excellence in Capabilities, Expertise, Quality,
Compatibility, Reliability and Service. The CDMO Leadership Awards teamed up
with ISR to determine the award recipients - 72 contract manufacturers were
assessed by 23 performance metrics in ISR’s annual Contract Manufacturing
Quality Benchmarking survey.
"We are honored and proud to receive this award in all six categories. This
broad recognition reflects the dedication of our team to help our customers
deliver much-needed medicines to the market," said Dr. Jean-Luc Herbeaux,
Hovione’s CEO. “This is not the first time Hovione is recognized by the CDMO
Leadership awards and winning these awards once again reinforces our commitment
to excellence and differentiation in the services we provide to our customers.”
“For over a decade, these awards have been the most meaningful for biopharma
organizations striving to obtain optimal outcomes from their outsourcing
activities. Our research arm, ISR Reports, which only surveys drug sponsors who
have worked directly and recently with specific CDMOs, ensures the validity of
these results. Our winners are your gold medalists of outsourcing,” said Louis
Garguilo, Chief Editor and Conference Chair of Outsourced Pharma.
Hovione has been expanding
(https://www.hovione.com/press-room/press-release/hovione-invests-170-million-ne
w-capacity-and-capabilities) worldwide, demonstrating the commitment to its
customers. Hovione has been investing in new laboratory and production assets
and innovative technologies
(https://www.hovione.com/press-room/press-release/hovione-expands-drug-product-o
ffering-new-manufacturing-line-dedicated-continuous-tableting) to meet customer
demand for integrated and differentiated services in manufacturing of drug
substances, particles and drug products.
About Hovione:
Hovione is an international company with over 60 years of experience in
pharmaceutical development and manufacturing operations. As a Contract
Development and Manufacturing Organization (CDMO)
(https://go.hovione.com/e/47122/ontract-manufacturing-services/8wjzq5/2436741121
?h=xIUzj2eUnalGXhlPJn3XyuRuixnG8bdX6YCeda_Eqg8) with a fully integrated
offering of services for drug substances, drug product intermediates and drug
products. The company has four FDA inspected sites
(https://go.hovione.com/e/47122/hovione-worldwide/8wjzq8/2436741121?h=xIUzj2eUna
lGXhlPJn3XyuRuixnG8bdX6YCeda_Eqg8) in the USA, Portugal, Ireland and China and
development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione
provides pharmaceutical customers services for the development and compliant
manufacture
(https://go.hovione.com/e/47122/-services-particle-engineering/8wjzqc/2436741121
?h=xIUzj2eUnalGXhlPJn3XyuRuixnG8bdX6YCeda_Eqg8) of innovative drugs, including
highly potent compounds, and customized product solutions across the entire
drug life cycle. In the inhalation area, Hovione offers a complete range of
services, from API, formulation development and devices. Hovione´s culture is
based on innovation, quality and dependability. Hovione was the first Chemical/
Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360,
EFCG and participates actively in industry quality improvement initiatives to
lead new global industry standards.
For more information, please visit www.hovione.com (http://www.hovione.com/) or
contact:
Vanessa Romeu | Communications Director | vromeu@hovione.com |Tel: +351 21 982
9000
Photo: https://mma.prnewswire.com/media/2018547/HOVIONE.jpg
Source: HOVIONE
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。